Dr. Hönle AG reported earnings results for the third quarter and nine months ended June 30, 2025. For the third quarter, the company reported sales was EUR 22.85 million compared to EUR 23.96 million a year ago. Net loss was EUR 0.907 million compared to EUR 0.265 million a year ago.
For the nine months, sales was EUR 70.02 million compared to EUR 72.09 million a year ago. Net loss was EUR 1.31 million compared to EUR 0.994 million a year ago. Basic loss per share from continuing operations was EUR 0.22 compared to EUR 0.17 a year ago. Diluted loss per share from continuing operations was EUR 0.22 compared to EUR 0.17 a year ago.